MD - CIK 0000893949
The table below shows Pediatrix Medical Group, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $271.09M | $206.57M | $137.32M | $166.94M | $76.74M | $204.62M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$18.30M | -$35.41M | -$48.18M | -$56.95M | -$53.07M | $815.51M |
| Dividends paid | - | - | - | - | - | - |
Pediatrix Medical Group, Inc. reported operating cash flow of $271.09M for fiscal year 2025. That is up 31.2% from $206.57M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $443.78M (FY 2016) to $271.09M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $86.68M | $1.70M | $919.00K | $88.51M | $4.72M | $8.49M |
| Financing cash flow | -$107.49M | -$14.48M | -$25.71M | -$487.55M | -$760.12M | -$4.16M |